Orna Therapeutics is a biotechnology company dedicated to designing and delivering a new class of fully engineered circular RNA (oRNA) therapeutics with the potential to change the way we treat disease. Their technology has applications across multiple disease areas including cancer, regenerative medicine, protein replacement, infectious diseases, and autoimmunity.

Orna Therapeutics is a biotechnology company dedicated to designing and delivering a new class of fully engineered circular RNA (oRNA) therapeutics with the potential to change the way we treat disease. Orna’s proprietary platform combines novel technology to create oRNAs that drive protein expression with validated and unique delivery solutions. 

MPM Capital

Novartis Institutes for Biomedical Research

Astellas Venture Management

Kite Pharma

Bristol Myers Squibb

F2 Ventures

Taiho Ventures

The Pags Group

Merck

BioImpact

Orna Therapeutics

COM:ORNATX

Orna Therapeutics

Analysis Not Available